Rankings
▼
Calendar
ENGN Q4 2022 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$8M
EPS (Diluted)
$-0.53
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$32,000
Balance Sheet
Total Assets
$131M
Total Liabilities
$4M
Stockholders' Equity
$127M
Cash & Equivalents
$456,995
← FY 2022
All Quarters
Q1 2023 →